Endsulin is Drug Discovery in United States that focus on Type I business. Founded in 2016. They cover business area such as Provider, medical research service, type I, gene therapy, glucose-inducible insulin transgene, (glucose inducible responsive element, GIRE, a method, glucose-regulated expression, active insulin, mammalian cell, patient, their liver.
2016
( 8 years old in 2024 )
Type I
-
504 South Rosa Road
Suite 200
Madison, WI 53719
United States
Private
Providermedical research servicetype Igene therapyglucose-inducible insulin transgene(glucose inducible responsive elementGIREa methodglucose-regulated expressionactive insulinmammalian cellpatienttheir liver
* We use standard office opening hours in near Endsulin's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Endsulin is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Endsulin business is focusing on Type I.
Endsulin headquarter office and corporate office address is located in 504 South Rosa Road Suite 200 Madison, WI 53719 United States.
Endsulin was founded in United States.
In 2024, Endsulin is currently focus on Type I sector.
Above is snippet of Google Trends for "Type I" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Endsulin, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
